Recent Finacing
Recent Raise
Nurix Therapeutics develops small-molecule therapies that modulate protein levels via E3 ligase–targeting using its DELigase DNA‑encoded library platform, applying structural, mechanism-driven UPS engineering to oncology and immuno-oncology.
